| Product Code: ETC7738964 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Generalized Anxiety Disorder Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Generalized Anxiety Disorder Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Generalized Anxiety Disorder Market - Industry Life Cycle |
3.4 Japan Generalized Anxiety Disorder Market - Porter's Five Forces |
3.5 Japan Generalized Anxiety Disorder Market Revenues & Volume Share, By Therapeutics, 2021 & 2031F |
3.6 Japan Generalized Anxiety Disorder Market Revenues & Volume Share, By Therapies, 2021 & 2031F |
3.7 Japan Generalized Anxiety Disorder Market Revenues & Volume Share, By Devices, 2021 & 2031F |
4 Japan Generalized Anxiety Disorder Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and acceptance of mental health issues in Japan |
4.2.2 Rising stress levels in the population due to work pressure and lifestyle changes |
4.2.3 Growing availability and acceptance of mental health therapies and treatments |
4.3 Market Restraints |
4.3.1 Stigma associated with seeking help for mental health issues in Japanese society |
4.3.2 Limited access to mental health professionals and services in certain regions of Japan |
4.3.3 High costs associated with mental health treatments and therapies |
5 Japan Generalized Anxiety Disorder Market Trends |
6 Japan Generalized Anxiety Disorder Market, By Types |
6.1 Japan Generalized Anxiety Disorder Market, By Therapeutics |
6.1.1 Overview and Analysis |
6.1.2 Japan Generalized Anxiety Disorder Market Revenues & Volume, By Therapeutics, 2021- 2031F |
6.1.3 Japan Generalized Anxiety Disorder Market Revenues & Volume, By Antidepressant, 2021- 2031F |
6.1.4 Japan Generalized Anxiety Disorder Market Revenues & Volume, By Buspirone, 2021- 2031F |
6.1.5 Japan Generalized Anxiety Disorder Market Revenues & Volume, By Benzodiazepines, 2021- 2031F |
6.1.6 Japan Generalized Anxiety Disorder Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Japan Generalized Anxiety Disorder Market, By Therapies |
6.2.1 Overview and Analysis |
6.2.2 Japan Generalized Anxiety Disorder Market Revenues & Volume, By Interpersonal Therapy, 2021- 2031F |
6.2.3 Japan Generalized Anxiety Disorder Market Revenues & Volume, By Behavior Therapy, 2021- 2031F |
6.2.4 Japan Generalized Anxiety Disorder Market Revenues & Volume, By Cognitive Behavioral Therapy, 2021- 2031F |
6.2.5 Japan Generalized Anxiety Disorder Market Revenues & Volume, By Mindfulness Based Cognitive Therapy, 2021- 2031F |
6.3 Japan Generalized Anxiety Disorder Market, By Devices |
6.3.1 Overview and Analysis |
6.3.2 Japan Generalized Anxiety Disorder Market Revenues & Volume, By Deep Brain Stimulation, 2021- 2031F |
6.3.3 Japan Generalized Anxiety Disorder Market Revenues & Volume, By Electroconvulsive Therapy, 2021- 2031F |
6.3.4 Japan Generalized Anxiety Disorder Market Revenues & Volume, By Transcranial Magnetic Stimulation, 2021- 2031F |
6.3.5 Japan Generalized Anxiety Disorder Market Revenues & Volume, By Vagus Nerve Stimulation, 2021- 2031F |
7 Japan Generalized Anxiety Disorder Market Import-Export Trade Statistics |
7.1 Japan Generalized Anxiety Disorder Market Export to Major Countries |
7.2 Japan Generalized Anxiety Disorder Market Imports from Major Countries |
8 Japan Generalized Anxiety Disorder Market Key Performance Indicators |
8.1 Average waiting time for patients to receive mental health services |
8.2 Number of mental health facilities and professionals per capita in Japan |
8.3 Percentage of individuals seeking help for anxiety disorders compared to previous years |
9 Japan Generalized Anxiety Disorder Market - Opportunity Assessment |
9.1 Japan Generalized Anxiety Disorder Market Opportunity Assessment, By Therapeutics, 2021 & 2031F |
9.2 Japan Generalized Anxiety Disorder Market Opportunity Assessment, By Therapies, 2021 & 2031F |
9.3 Japan Generalized Anxiety Disorder Market Opportunity Assessment, By Devices, 2021 & 2031F |
10 Japan Generalized Anxiety Disorder Market - Competitive Landscape |
10.1 Japan Generalized Anxiety Disorder Market Revenue Share, By Companies, 2024 |
10.2 Japan Generalized Anxiety Disorder Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here